 Fulgent Genetics, Inc. NASDAQ:FLGT Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Company Participants Melanie Solomon - IR Ming Hsieh - CEO Paul Kim - CFO Brandon Perthuis - Chief Commercial Officer Dr. Ray Yin - President and Chief Scientific Officer, Fulgent Pharma Conference Call Participants Dan Leonard - Credit Suisse Operator Hello and welcome to the Fulgent Genetics Q3 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. 